A clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies for degenerative diseases. Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancers and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in Ch...
A clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies for degenerative diseases. Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancers and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.